Company page

Ascletis Pharma, Inc.

Ascletis Pharma, Inc. is a public company listed on the Hong Kong Stock Exchange under the ticker 1672. The company has a market capitalization of approximately HKD 1.18 billion. Ascletis focuses on the development and commercialization of innovative therapies for various diseases.

1672:HKEXUpdated September 4, 2026
Ascletis Pharma, Inc. logo
Ticker
1672:HKEX
Asset type
Stock
Market cap
$1.38B
Sector
Health Technology
Industry
Biotechnology
Exchange
HKEX
Currency
HKD